ID   86HG39
AC   CVCL_7259
SY   86HG-39; 86-HG-39
DR   Wikidata; Q54605438
RX   PubMed=1460090;
RX   PubMed=1708926;
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
CH   CVCL_7892 ! 2D9 [Human glioblastoma]
//
RX   PubMed=1460090; DOI=10.1016/0165-5728(92)90191-M;
RA   Daubener, Walter
RA   Zennati, Samira Seghrouchni
RA   Wernet, Peter
RA   Bilzer, Thomas
RA   Fischer, Hans Georg
RA   Hadding, Ulrich
RT   "Human glioblastoma cell line 86HG39 activates T cells in an antigen
RT   specific major histocompatibility complex class II-dependent manner.";
RL   J. Neuroimmunol. 41:21-28(1992).
//
RX   PubMed=1708926; DOI=10.1007/BF01600156;
RA   Bilzer, Thomas
RA   Stavrou, Dimitrios
RA   Dahme, Erwin
RA   Keiditsch, Ernst
RA   Burrig, Karl-Friedrich
RA   Anzil, Archinto Peter
RA   Wechsler, Wolfgang
RT   "Morphological, immunocytochemical and growth characteristics of three
RT   human glioblastomas established in vitro.";
RL   Virchows Arch. A. Pathol. Anat. Histopathol. 418:281-293(1991).
//